Refusing the SAVE Act Should End Several Careers

Washington ignores you—until you get loud. In this clip, Larry O’Connor sits down with AMAC’s Andy Mangione to break down two huge fights: lower prescription drug costs through PBM reform (including “delinking” profits from inflated list prices) and the SAVE Act’s stalled path in the U.S. Senate. They explain how grassroots pressure, voter accountability, and a “talking filibuster” strategy could force action—proving your voice still matters in Washington.